Evaxion Biotech AS (EVAX) — Financial Flexibility Index
Evaxion Biotech AS (EVAX) has a Financial Flexibility Index of -0.58x as of December 2025. Free cash flow of $-6.63 Million (operating CF $-6.65 Million minus capex $11.03K) represents -1% of total liabilities ($11.37 Million). Check Evaxion Biotech AS tangible book value ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Evaxion Biotech AS Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Evaxion Biotech AS across 8 annual periods. For the full cash flow conversion analysis, see Evaxion Biotech AS cash flow conversion.
Annual Financial Flexibility Index for Evaxion Biotech AS (2018–2025)
Year-by-year free cash flow to debt coverage for Evaxion Biotech AS. Explore Evaxion Biotech AS (EVAX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.58x | $-6.63 Million | $-6.65 Million | $11.37 Million | ▲ +36.2% |
| 2024 | -0.92x | $-12.94 Million | $-12.94 Million | $14.14 Million | ▲ +8.4% |
| 2023 | -1.00x | $-17.60 Million | $-17.69 Million | $17.62 Million | ▲ +46.2% |
| 2022 | -1.86x | $-25.48 Million | $-25.77 Million | $13.72 Million | ▲ +30.3% |
| 2021 | -2.66x | $-20.57 Million | $-21.93 Million | $7.73 Million | ▼ -8.9% |
| 2020 | -2.44x | $-12.04 Million | $-12.44 Million | $4.93 Million | ▲ +39.6% |
| 2019 | -4.04x | $-6.96 Million | $-7.03 Million | $1.72 Million | ▼ -1825.3% |
| 2018 | -0.21x | $-1.98 Million | $-1.99 Million | $9.44 Million | — |